KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Non-Current Debt: 2009-2025

Historic Non-Current Debt for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $2.2 billion.

  • Charles River Laboratories International's Non-Current Debt fell 6.07% to $2.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.2 billion, marking a year-over-year decrease of 6.07%. This contributed to the annual value of $2.2 billion for FY2024, which is 15.37% down from last year.
  • Per Charles River Laboratories International's latest filing, its Non-Current Debt stood at $2.2 billion for Q3 2025, which was down 6.30% from $2.3 billion recorded in Q2 2025.
  • Over the past 5 years, Charles River Laboratories International's Non-Current Debt peaked at $3.0 billion during Q2 2022, and registered a low of $2.2 billion during Q3 2025.
  • For the 3-year period, Charles River Laboratories International's Non-Current Debt averaged around $2.5 billion, with its median value being $2.5 billion (2025).
  • Its Non-Current Debt has fluctuated over the past 5 years, first spiked by 46.97% in 2021, then fell by 15.37% in 2024.
  • Over the past 5 years, Charles River Laboratories International's Non-Current Debt (Quarterly) stood at $2.7 billion in 2021, then rose by 1.65% to $2.7 billion in 2022, then dropped by 2.23% to $2.6 billion in 2023, then declined by 15.37% to $2.2 billion in 2024, then dropped by 6.07% to $2.2 billion in 2025.
  • Its Non-Current Debt was $2.2 billion in Q3 2025, compared to $2.3 billion in Q2 2025 and $2.5 billion in Q1 2025.